PHARMExcel’s top picks from the speaker line up:
Delivering trials through NHS Organisations
Prof Sandip Mitra, Deputy Director, NIHR Devices for Dignity MedTech Co-Operative and Consultant Nephrologist & Professor of Renal Medicine, Manchester University NHS Foundation Trust
Leveraging local relationships for best in-country solutions to accelerate global drug development
David Chia, Senior Business Development Manager in Business Development United Kingdom, Novotech
Diana Filipescu, Business Development Manager, EastHORN
- Partnering with a CRO to access European infrastructure, in depth local knowledge, site relationships and diverse patient populations
- Strategies to fast-track clinical trial start-up and patient recruitment timelines
- Are you ready for EU CTR? Challenges and lessons learned
How NIHR infrastructure can enhance industry and commercial collaboration in clinical trials: the Greater Manchester Example
Professor Ian Bruce, Director, NIHR Manchester Biomedical Research Centre
- Outline of current NIHR infrastructure
- How NIHR infrastructure can support industry collaborations
- Post Covid RESET and research recovery
Sponsor and NHS Site Collaboration to accelerate set-up timelines
Rachel Haines, Director of Clinical Operations, Rinri Therapeutics
Shaun Cochrane, Deputy Director R&D, Guy’s and St Thomas’ NHS Foundation Trust
- Current challenges of heavily waiting timelines over expertise
- How early Sponsor-initiated collaboration can shorten timelines
- Shared aims of accelerating post-submission site feasibility and approval timelines
Building back a thriving, competitive life science sector in the UK & Ireland
Barbara Hepworth Jones, Director Capability Building at GSK
Professor Ian Bruce, Director, NIHR Manchester Biomedical Research Centre
Janet Messer, Director of Approvals Service at Health Research Authority
Oliver Buckley-Mellor, Innovation and Research Policy Manager (Clinical), The Association of the British Pharmaceutical Industry (ABPI)
Dr Alison McMorn, PhD – VP, Clinical Development, Amo Pharma Ltd
- Exploring maintenance and growth of research delivery in NHS sites
- Appreciating global life science industry timelines; highlighting regulatory approval, ethics reviews, and the time it takes to set-up at a site, and recruit the first participants
- Unlocking costing for commercial contract research
- Addressing clinical capacity within the NHS in order to increase revenue and increase trials based in the UK
- Discussing MHRA Introductory measures to streamline the process of running trials making the UK a ‘more attractive’ place to conduct clinical trials
